• Guidance
  • Interesting shortcuts
  • EFFRA Members' Perspectives
  • News Dashboard
  • Structured Wiki
    • Search
    • FoF and Made in Europe Partnership
    • Demonstrators, pilots, prototypes
    • Exploitable result(s)
    • Significant innovations and lessons learned, training aspects
    • Report - Video - Presentation - Publication....?
    • Project clusters
    • EFFRA member perspectives
    • Manufacturing future products
    • Manufacturing performance characteristics
    • Technologies and enablers
    • ICT performance characteristics
    • Standards, technical committees and working groups
    • Contribution of R&I projects to standardisation
    • Regulatory and policy aspects
    • Standards - other classifications
    • Business model aspects
    • Pathways
    • MiE SRIA R&I Priorities
    • MiE WP26-27 Consultation - Potential Research Topics only
    • MiE WP26-27 Consultation and context pointers
    • MiE WP26-27 Consultation with pointers to WP25-27 consultation
    • MiE KPIs
    • Relevant (future) calls
    • EU-Programme-Call
    • NACE code
    • EFFRA Organisations - members
    • EFFRA WG pointers
  • Pathways
    • Pathways
  • Projects
    • Projects
  • Resources
    • Resources
  • Project ideas
    • Project ideas
  • People & organisations
    • People
    • Organisations
  • portal@effra.eu
  • Visit the EFFRA website
    • Login
  • Structured Wiki
  • EU-Programme-Call
  • Horizon Europe
  • HORIZON.2 Global Challenges and European Industrial Competitiveness
  • HORIZON.2.1 Health
  • HORIZON.2.1.3 Non-Communicable and Rare Diseases

HORIZON.2.1.3 Non-Communicable and Rare Diseases

  • HORIZON-HLTH-2021-DISEASE-04
    • HORIZON-HLTH-2021-DISEASE-04-01 Improved supportive, palliative, survivorship and end-of-life care of cancer patients
  • HORIZON-HLTH-2021-GACD-08-IBA
    • HORIZON-HLTH-2021-GACD-08-01-IBA Grant to the Global Alliance for Chronic Diseases (GACD)
  • HORIZON-HLTH-2022-DISEASE-06-two-stage
    • HORIZON-HLTH-2022-DISEASE-06-04-two-stage Development of new effective therapies for rare diseases
  • HORIZON-HLTH-2022-DISEASE-07
    • HORIZON-HLTH-2022-DISEASE-07-03 Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)
  • HORIZON-HLTH-2023-DISEASE-03
    • HORIZON-HLTH-2023-DISEASE-03-01 Novel approaches for palliative and end-of-life care for non-cancer patients
    • HORIZON-HLTH-2023-DISEASE-03-03 Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)
    • HORIZON-HLTH-2023-DISEASE-03-06 Towards structuring brain health research in Europe
    • HORIZON-HLTH-2023-DISEASE-03-07 Relationship between infections and non-communicable diseases
  • HORIZON-HLTH-2023-DISEASE-07
    • HORIZON-HLTH-2023-DISEASE-07-01 European Partnership on Rare Diseases
  • HORIZON-HLTH-2023-IND-06
    • HORIZON-HLTH-2023-IND-06-04 Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines
  • HORIZON-HLTH-2024-PHUN-15-IBA
    • HORIZON-HLTH-2024-PHUN-15-01-IBA Presidency event - Hungary. Hungarian conference on Brain health
Powered by Chris Decubber BV